To predict the radiosensitivity of nasopharyngeal carcinoma using intravoxel incoherent motion MRI at 3.0 T

被引:19
|
作者
Chen, Wen Bo [2 ]
Zhang, Bin [1 ,3 ]
Liang, Long [1 ]
Dong, Yu Hao [1 ,4 ]
Cai, Guan Hui [2 ]
Liang, Chang Hong [1 ]
Lan, Bo Wen [2 ]
Zhang, Shui Xing [1 ]
机构
[1] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China
[2] HuiZhou Municipal Cent Hosp, Dept Radiol, Huizhou, Guangdong, Peoples R China
[3] Southern Med Univ, Guangzhou, Guangdong, Peoples R China
[4] Shantou Univ, Coll Med, Shantou, Guangdong, Peoples R China
关键词
intravoxel incoherent motion; MRI; nasopharyngeal carcinoma; IMRT; radiosensitivity; DIFFUSION-WEIGHTED MRI; CONTRAST-ENHANCED MRI; NECK TUMORS; HEAD; PERFUSION; CANCER; DIFFERENTIATION; COEFFICIENTS; EXPERIENCE; CIRRHOSIS;
D O I
10.18632/oncotarget.17367
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate intravoxel incoherent motion (IVIM) MRI for evaluating the sensitivity of radiotherapy on nasopharyngeal carcinoma (NPC). Results: The reproducibility between intra-observer and inter-observer was relatively good. D (0.72x10(-3) mm(2)/s +/- 0.14 vs. 0.54x10(-3) mm(2)/s +/- 0.23; P < 0.001) and D* (157.92x10(-3) mm(2)/s +/- 15.21 vs. 120.36x10(-3) mm(2)/s +/- 10.22; P < 0.0001) were significantly higher in effective group than poor-effective group, whereas the difference of f (18.79%+/- 2.51 vs. 16.47%+/- 1.51) and ADC (1.21x10(-3) mm(2)/s +/- 0.11 vs. 1.33x10(-3) mm(2)/s +/- 0.23) could not reach statistical significant between the 2 groups (P > 0.05). Conclusions: IVIM may be potentially useful in assessing the radiosensitivity of NPC. The higher D value combining with higher D* value might indicate the more radiosensitive of NPC, and increased D* might reflect increased blood vessel generation and parenchymal perfusion in NPC. Materials and Methods: Sixty consecutive patients (20 female, range, 27-83 years, mean age, 52 years) newly diagnosed NPC in the stage of T3 or T4 were enrolled. Forty-two of them were divided into effective group clinically after a standard radiotherapy according to the RECIST criteria. IVIM with 13 b-values (range, 0-800 s/mm(2)) and general MRI were performed at 3.0T MR scanner before and after radiotherapy. The parameters of IVIM including perfusion fraction (f), perfusion-related diffusion (D*), pure molecular diffusion (D) and apparent diffusion coefficient (ADC) were calculated. Two radiologists major in MRI diagnose analyzed all images independently and placed regions of interest (ROIs). Intra-class correlation coefficient (ICC) was used to evaluate intra-observer and inter-observer agreement. And MannWhitney test was used to assess the differences between the two groups.
引用
收藏
页码:53740 / 53750
页数:11
相关论文
共 50 条
  • [1] Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site
    Zhang, Shui-xing
    Jia, Qian-jun
    Zhang, Zhong-ping
    Liang, Chang-hong
    Chen, Wen-bo
    Qiu, Qian-hui
    Li, He
    EUROPEAN RADIOLOGY, 2014, 24 (08) : 1998 - 2004
  • [2] Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma
    Jia, Qian-Jun
    Zhang, Shui-Xing
    Chen, Wen-Bo
    Liang, Long
    Zhou, Zheng-Gen
    Qiu, Qian-Hui
    Liu, Zai-Yi
    Zeng, Qiong-Xin
    Liang, Chang-Hong
    EUROPEAN RADIOLOGY, 2014, 24 (12) : 3076 - 3087
  • [3] Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site
    Shui-xing Zhang
    Qian-jun Jia
    Zhong-ping Zhang
    Chang-hong Liang
    Wen-bo Chen
    Qian-hui Qiu
    He Li
    European Radiology, 2014, 24 : 1998 - 2004
  • [4] Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma
    Mao, Jiaji
    Shen, Jun
    Yang, Qihua
    Yu, Taihui
    Duan, Xiaohui
    Zhong, Jinglian
    Phuyal, Prakash
    Liang, Biling
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 44 (06) : 1556 - 1564
  • [5] The Role of Intravoxel Incoherent Motion MRI in Predicting Early Treatment Response to Chemoradiation for Metastatic Lymph Nodes in Nasopharyngeal Carcinoma
    Lu, Liyan
    Li, Yuehua
    Li, Wenbin
    ADVANCES IN THERAPY, 2016, 33 (07) : 1158 - 1168
  • [6] Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI
    Ai, Qi-Yong
    King, Ann D.
    Chan, Janet S. M.
    Chen, Weitian
    Chan, K. C. Allen
    Woo, John K. S.
    Zee, Benny C. Y.
    Chan, Anthony T. C.
    Poon, Darren M. C.
    Ma, Brigette B. Y.
    Hui, Edwin P.
    Ahuja, Anil T.
    Vlantis, Alexander C.
    Yuan, Jing
    EUROPEAN RADIOLOGY, 2019, 29 (10) : 5627 - 5634
  • [7] Intravoxel Incoherent Motion Diffusion Weighted Magnetic Resonance Imaging for Differentiation Between Nasopharyngeal Carcinoma and Lymphoma at the Primary Site
    Yu, Xiao-Ping
    Hou, Jing
    Li, Fei-Ping
    Wang, Hui
    Hu, Ping-Sheng
    Bi, Feng
    Wang, Wei
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2016, 40 (03) : 413 - 418
  • [8] Perfusion and diffusion characteristics of endometrial malignancy based on intravoxel incoherent motion MRI at 3.0 T: comparison with normal endometrium
    Liu, Jingyan
    Wan, Yeda
    Wang, Zhi
    Qi, Yang
    Qu, Pengpeng
    Liu, Yixin
    ACTA RADIOLOGICA, 2016, 57 (09) : 1140 - 1148
  • [9] Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma
    Yu Xiao-ping
    Hou Jing
    Li Fei-ping
    Hu Yin
    Lu Qiang
    Wang Lanlan
    Wang Wei
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 43 (05) : 1179 - 1190
  • [10] Intravoxel incoherent motion radiomics nomogram for predicting tumor treatment responses in nasopharyngeal carcinoma
    Guo, Yihao
    Dai, Ganmian
    Xiong, Xiaoli
    Wang, Xiaoyi
    Chen, Huijuan
    Zhou, Xiaoyue
    Huang, Weiyuan
    Chen, Feng
    TRANSLATIONAL ONCOLOGY, 2023, 31